HIV / AIDs

HIV News: New Guidelines For HIV Antiretroviral Treatment (ART) Will See Dolutegravir Prescribed For Individuals Newly Diagnosed With HIV

Source: HIV News Oct 19, 2020 4 years ago

HIV News: University of British Columbia researchers have concluded a new study of which the findings are set to change international treatment recommendations for individuals who are newly diagnosed with HIV, an update that could affect nearly two million people per year worldwide. The research found that the antiviral dolutegravir is the optimal medication for first-line treatment for i...

WARNING! Commonly Used HIV Drug Truvada Induces A Type I/III Interferon-Associated Signature And Inflammation Throughout The Gut

Source: HIV Drugs Sep 23, 2020 4 years ago

HIV Drugs: According to researchers from the University of Washington-Seattle, the commonly used HIV drug that is to treat those infected and also individuals using it as a prophylaxis or in PrEP protocols can induce a type I/III interferon-associated signature and inflammation throughout the gut. It should be noted that long term inflammation of any kind can lead to a variety of chronic ...

BREAKING! HIV News: Antibiotics Called Pleicomacrolides Allows Immune System To Kill HIV Infected Cells According to University Of Michigan Study

Source: HIV News Sep 08, 2020 4 years ago

HIV News: Researchers from University of Michigan Health System have discovered that a class of antibiotics called pleicomacrolides allows the immune system to kill HIV infected cells by inhibiting the Nef proteins. The research finds are published in the Journal of The Proceedings of the National Academy Of Sciences of The United States Of America (Concanamycin A counteracts HIV-1 Nef to...

HIV News: Another Long-Acting, Injectable Drug CPT31 That Last For 3 Months To Treat HIV Coming Soon.

Source: HIV News Aug 23, 2020 4 years ago

HIV News: The trend for HIV drug research is now shifting towards drugs with long lasting effects without the need for HIV patients to adhere to stringent daily regimens and doses which can be quiet stressful at times. Scientists from the University of Utah Health in collaboration with researchers from the National Institute of Allergy and Infectious Diseases (NIAID), Beth Israel Deacones...

HIV Drug News: Latest Study Shows Fingolimod, A Multiple-Sclerosis Drug Blocks HIV Infections And Eradicates Latent Virus Reservoirs

Source: HIV Drug News Aug 15, 2020 4 years ago

HIV Drug News: Researchers at the George Washington University in a new study have discovered that Fingolimod, a US FDA-approved immunosuppressive drug used to treat multiple sclerosis flare-ups, may be used to effectively block HIV infection and reduce the latent virus reservoir. The research findings were published in the journal: PLOS Pathogens. https://journals.plos.org/plospathogens/...

HIV Research: Study Warns That People Living Longer With HIV At Risk Of Myocardial Steatosis, Heart Failure, Kidney Damage And Other Health Issues

Source: HIV Research Aug 02, 2020 4 years ago

HIV Research: The significant impact and prevalence of heart disease and other critical comorbidities on an aging global population with human immunodeficiency virus (HIV) have emerged from a suite of articles in The Journal of Infectious Diseases that contains the first swath of important data from the world's largest study of cardiovascular disease (CVD) prevention in people with H...

COVID-19 And HIV: Icahn Researchers Say HIV May Not Worsen COVID-19 Outcomes

Source: COVID-19 And HIV Jul 05, 2020 5 years ago

COVID-19 And HIV: Individuals with HIV who were hospitalized with COVID-19 did not have worse results than COVID-19 patients without HIV, according to new research by Icahn School of Medicine at Mount Sinai. The research findings were published in the journal: Clinical Infectious Diseases https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa880/5864410?searchresult=1 Study...

HIV Drugs: US FDA Approves Rukobia (Fostemsavir) To Treat Patients With Multidrug Resistant HIV Infection

Source: HIV Drugs Jul 04, 2020 5 years ago

HIV Drugs: The drug Rukobia (fostemsavir) has been approved by The U.S. FDA for adults living with HIV who have tried multiple HIV medications and whose HIV infection cannot be successfully treated with other therapies because of resistance, intolerance or safety considerations. Rukobia (Fostemsavir) is a new type of antiretroviral medication to be taken twice daily by mouth. It is a prodrug, whi...

BREAKING NEWS! HIV: Study Shows New HIV Drug Lenacapavir Taken Once Every Six Months Can Maintain Low Viral Loads Effectively

Source: HIV and Lenacapavir Jul 02, 2020 5 years ago

HIV and Lenacapavir: Gilead scientists are reporting an early step toward an HIV drug that could potentially be taken only a couple of times per year. A new study showed that a single injection of the experimental drug, called lenacapavir, was able to lower blood levels of HIV in a small group of patients. And it was capable of maintaining active levels in the blood for more than six...

HIV: Research From Emory University Shows That New Adjuvant 3M-052 Extends Immunity Against HIV

Source: Thailand HIV Jun 21, 2020 5 years ago

HIV: Immunology researchers from the Yerkes National Primate Research Center and the Emory Vaccine Center (EVC) are first to show a new adjuvant, 3M-052, helps induce long-lasting immunity against HIV. The research findings are published today in the journal: Science Immunology. https://immunology.sciencemag.org/content/5/48/eabb1025 Significantly, in this pre-clinical study&n...

HIV Can Harbor In Brain Cells According To Latest Study

Source: Thailand HIV Jun 12, 2020 5 years ago

HIV: Medical researchers from Rush University Medical Center, Temple University School of Medicine and the University Of Texas Medical Branch have found that astrocytes, a type of brain cell can harbor HIV and then spread the virus to immune cells that traffic them out of the brain and into other organs. It was observed that HIV moved from the brain via this route even when the virus was ...

HIV Research: CD127 Proteins Identified As Sites Of Latent Reservoirs Of HIV

Source: HIV Research May 09, 2020 5 years ago

HIV Research: Medical researchers have known for a long time that despite the advancements in antiretroviral therapy, varying amounts HIV virus remains in infected individuals forever, hiding in small reservoirs of cells of the immune system. Should ever these individuals discontinue the antiretroviral therapy, the HIV virus almost always rebounds rapidly from the reservoirs, causing deadly sympto...

New Study Shows That Vitamin E Can Treat Non-alcoholic Steatohepatitis (NASH) In HIV Patients

Source : Thailand Medical News Feb 19, 2020 5 years ago

Non-alcoholic steatohepatitis (NASH) is a severe form of nonalcoholic fatty liver disease (NAFLD) and is characterized by liver inflammation and cell damage. It is a potentially dangerous condition that can progress to cirrhosis or liver cancer. Unfortunately, HIV patients tend to have a high prevalence of the disease. A new study by McGill University, Canada has found that Vitamin E can ...

German Researchers Develop Less Toxic And More Effective HIV Treatment Using Broadly Neutralizing Antibodies That Also Prevent Viral Resistance

Source: Thailand Medical News Feb 01, 2020 5 years ago

Typically antiretroviral drugs are the gold standard for the treatment of HIV infection. They are highly effective in suppressing replication of the virus but require lifelong daily application and can be associated with side effects. Due to the high mutability of HIV and its capacity for rapid adaptation, combinations of antiretroviral agents are required to prevent the development of drug resist...

HIV Breakthrough: Researchers Reverse HIV Latency Paving Way For Potential Cure

Source: Thailand Medical News Jan 23, 2020 5 years ago

More than 42 million people are infected with HIV worldwide, about 1.5 million people in the United States alone. Currently, people with HIV take antiretroviral therapy (ART), which can suppress HIV to undetectable levels in blood, but the virus persists throughout the body in latently infected resting CD4+ T cells. The immune system cannot recognize these cells and no current therapies can elimin...

New Study On Understanding Mechanisms Of Antiviral Drugs Sheds Light of Ways to Develop Newer Anti-Resistant Drugs For HIV And Hepatitis B

Source: Thailand Medical News Jan 09, 2020 5 years ago

A research discovery by Florida State University College of Medicine researchers is expected to open the door for new and more potent treatment options for many of the more than 45 million people worldwide infected with the HIV virus and for others chronically ill with hepatitis B. Professor Dr Zucai Suo of the FSU College of Medicine. Credit: Colin Hackley/FSU Their study has established for t...

Study By Oregon Health & Science University Shows That Single Dose Of Antibodies Can Knock Out HIV In Newborns

Source: Thailand Medical News Jan 07, 2020 5 years ago

New nonhuman primate research suggests for the first time that a single dose of an antibody-based treatment can prevent HIV transmission from mother to baby. The findings are being published in the journal Nature Communications. The time or period when that single dose is given is key, however. The study found rhesus macaque newborns did not develop the monkey form of HIV, called SHIV, whe...

Despite Early Treatment, HIV Still Attacks Brains Of Young Children

Source: Thailand Medical News Dec 18, 2019 5 years ago

Despite early antiretroviral therapy, or ART, has ensured less deadly outcomes for children living with and exposed to HIV, studies show the virus still may affect the brain. HIV may disrupt neurodevelopment, affecting how children learn, reason and function. Dr Michael Boivin, professor and director of the Psychiatry Research Program in the Michigan State University College of Osteopathic Medi...

Spread Of HIV In Human Tissues Can Be Reduced By Vesicles Secreted By Certain Bacteria Strains

Source: Thailand Medical News Dec 12, 2019 5 years ago

A study of human cells and tissues by researchers at the National Institutes of Health and the University of Bologna, Italy has shown that Nano-sized vesicles released by certain bacteria that inhabit the vagina may protect against HIV infection. Typically known as extracellular vesicles, these bubble-like particles are produced by many kinds of cells and are thought to transport molecules...

Research Indicates That Babies Born With HIV Should Start Antiretrovirals Immediately

Source: Thailand Medical News Nov 30, 2019 5 years ago

For babies are born with HIV, starting treatment within hours to days is critical and important according to a new study led by researchers from Harvard. Unfortunately the norm in many countries is to wait for weeks or even months. The study findings, from a small but unique study in Botswana, could influence care in Africa and other regions hit hard by the virus. They also might offer a ...

Scripps Research, California Releases Promising Results From Experimental HIV Vaccine

Source: Thailand Medical News Nov 25, 2019 5 years ago

Researchers at Scripps Research, California and the nonprofit vaccine research organization IAVI who are developing an experimental HIV vaccine has reached an important milestone by eliciting antibodies that can neutralize a wide variety of HIV strains. The tests, in animal models,showed that these “broadly neutralizing” antibodies, or bnAbs, targeted at least two critical sites on ...

HIV Patients And Even Doctors Not Aware Of Past Study That Links HIV With Break Down Of Intestinal Lining

Source: Thailand Medical News Nov 21, 2019 5 years ago

Despite a few past research studies that links HIV with 'erosion" of the gut's intestinal linings, leading to inflammation and also the ‘leaky gut” syndrome, many HIV patients and even doctors are not aware of this. In one past research in 2014, researchers at University of California, Davis had made some surprising discoveries about the body's initial response...

Study Shows Those With HIV Are At High Risk Of Sudden Cardiac Deaths

Source: Thailand Medical News Nov 15, 2019 5 years ago

In a study by researchers from Johns Hopkins University School of Medicine comparing medical information from portable EKG patch data from men living with HIV and also men without it, the researchers report they have found more variability of the electrical "reset" period between heartbeats known as the QT interval in men living with the virus, which may contribute to the increased...

Study Shows That Women With HIV Experience Menopause Earlier

Source: Thailand Medical News Nov 11, 2019 5 years ago

A new study demonstrates that women with HIV are more likely to enter the menopause transition at an average age of 48 years, 3 years younger than the general population. Study results are published online in Menopause, the journal of The North American Menopause Society (NAMS). Typically, newly diagnosed HIV-positive patients who adhere to the latest therapy protocols are expected to...

Breaking News: AGT103-T, New Drug By American Gene Technologies Developed To Cure HIV/AIDS Unveiled

Source: Thailand Medical News Nov 10, 2019 5 years ago

A group of medical and genomic researchers in Maryland from a company called American Gene Technologies announced that they have the answer for curing HIV/AIDS using gene therapy. The company hopes to initiate medical trials of a new gene therapy drug that it says can cure HIV. American Gene Technologies (AGT), a Rockville-based medical research company, has submitted a Investigational New...

Abbott Discovers New Strain of HIV

Source: Thailand Medical News Nov 07, 2019 5 years ago

Abbott announced today that a team of its scientists identified a new subtype of the human immunodeficiency virus (HIV), called HIV-1 Group M, subtype L.1 The findings, published today in the Journal of Acquired Immune Deficiency Syndromes (JAIDS), show the role next-generation genome sequencing is playing in helping researchers stay one step ahead of mutating viruses and avoiding n...

Tesamorelin (Egrifta) Reverses Signs of Liver Disease In Individuals With HIV

Source: Thailand Medical News Oct 26, 2019 5 years ago

Medical researchers from the US National Institutes of Health and the Massachusetts General Hospital (MGH) in Boston report that the injectable hormone tesamorelin (Egrifta) reduces liver fat and prevents liver fibrosis (scarring) in people living with HIV. Dr Anthony S. Fauci,NIAID Director (NIAID is one of the entities under the NIH) commented in a phone interview with Thailand Medical ...

Selenium Helps To Reduce HIV Viral Loads and Also Prevent CD4 Levels From Declining

Source: Thailand Medical News Oct 24, 2019 5 years ago

From 2007 to 2018, there has been more than 37 studies that show that Selenium supplementation is good for HIV patients. Selenium supplementation has demonstrated the ability to reduce viral loads of the HIV virus while also preventing CD4 levels from declining and helping it achieve moderate gains. Todate, there are been no known reactions or contraindications for those taking antiretrov...

Researchers Discover Ways To Deal With HIV Reservoirs To Create Longer Periods Of Virus Suppression And Possible Cure

Source: Thailand Medical News Oct 23, 2019 5 years ago

An new research study involving an international collaboration that included the University of Cape Town (UCT), Centre for the AIDS Program of Research in South Africa (CAPRISA) and the University of North Carolina at Chapel Hill (UNC) has revealed an unexpected finding that could lead to better therapies towards reducing the HIV reservoir, a major barrier to developing a cure for HIV. The reservo...

Descovy Approved As Second PrEP Drug To Prevent HIV Infection

Source: Thailand Medical News Oct 05, 2019 5 years ago

The US FDA has approved second PrEXp (pre-exposure prophylaxis) drug, Descovy (emtricitabine 200 mg and tenofovir alafenamide 25 mg) to help prevent HIV infections. The drug is for in at-risk adults and adolescents weighing at least 35kg for HIV-1 pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection from sex, excluding those who have receptive vaginal sex. Descovy is not indicated...

Guide Of Micronutrients, Antioxidants, Health Supplements and Herbs For HIV Patients

Source: Thailand Medical News Sep 25, 2019 5 years ago

Thailand Medical News is pleased to present this simple guide with regards to essential micronutrients, health supplements and herbal products for people living with HIV. It is not mean for anyone to abstain from their prescribed antiretroviral therapies and before commencing any consumption any of these products, always consult your doctors first. Micronutrients All vitamins and minerals are ...

New duoCAR-T Therapy Study Shows Promising Future For HIV Cure

Source: Thailand Medical News Sep 24, 2019 5 years ago

CAR-T, a type of immunotherapy may have made its name as the cancer breakthrough of this century, but its roots dig far back to one of humanity’s other terrifying medical enemy: HIV. CAR-T is a type of treatment in which a patient's T cells (a type of immune system cell) are changed in the laboratory so they will attack cancer cells. T cells are taken from a patient’s blood. Then t...

Chronic Diseases That Long-Term HIV Patients Will Face

Source: Thailand Medical News Sep 23, 2019 5 years ago

Longterm patients will ultimately face increased incidence of heart disease, COPD, Tuberculosis and bone fractures according to a new study. These are the areas that HIV patients need to take extra care off besides their antiretroviral regimens. Academics from Anglia Ruskin University (ARU) in Cambridge and the Medical University of Vienna conducted the first ever large-scale review into th...

New Long-Acting Injectable Multi-Drug Implant HIV Treatment

Source: Thailand Medical News Sep 21, 2019 5 years ago

For those on Antiretroviral therapy for prevention or treatment of HIV, whether on a single pill or combo regimen, it can be burdensome making sure the drugs are consumed without fail at the right times despite having a busy daily schedule. Those days might soon be over thanks to medical researchers across multiple departments at the University of North Carolina who collaborated on a seven-y...

RV144 HIV Vaccine Trials Shows Cross Clade Immune Responses

Source: Thailand Medical News Sep 20, 2019 5 years ago

Results of a study that was conducted in South Africa using the RV144/Thai vaccine regimen that showed modest protection in an efficacy study conducted in Thailand, where clades B and E are prominent indicated significant cellular and antibody responses in study participants with clade C as the dominant circulating strain of HIV. "Trial Responses Dispels The Notion That Each Strain or Clade...

Newly Developed Protein Drug Shows Promise In Suppressing And Maybe Even Eradicating HIV Infection

Source: Thailand Medical News Aug 08, 2019 5 years ago

A new potential medication that works with an HIV-infected person's own body to further suppress the ever present but silent virus that available HIV treatments are unable to combat has been discovered by a team of medical scientist from University of Texas Medical Branch at Galveston. In an exclusive interview with Thailand Medical News, lead author Assistant Professor Haito Hu comme...

START Study Shows That Initiating ART For Individuals With Low Viral Loads Has More Benefits In The Long Term

Source: Thailand Medical News Jul 15, 2019 6 years ago

Findings from the recent START study involving 4684 adult HIV-positive patients from various countries showed that starting antiretroviral therapy (ART) has significant benefits and entails few risks for individuals with a low pre-treatment viral load. All the patients in the study had a CD4 cell count above 500 cells/mm3 and were randomised to start immediate ART or to defer therapy until th...

Discovery Of New Type of Immune Cells,CD11c+, Leads To New HIV Treatment Strategy

Source: Thailand Medical News Jun 22, 2019 6 years ago

New immunity cells known as CD11c+ dendritic cells have been identified by a team of researchers from The Westmead Institute For Medical Research in Sydney.These CD11c+ dendritic cells are extremely susceptible to the HIV virus and can transmit the virus to other cells especially the CD4 T Cells. These CD11c+ dendritic cells are a type of dendritic cells that play a role in capturing any i...

Keytruda, An Immunotherapy Drug Safe For Treating HIV Patients With Cancer

Source: Thailand Medical News Jun 04, 2019 6 years ago

Most HIV patients have a 60% risk of developing a form of cancer during their life-span. Cancers like Lymphoma, Lung Cancer, Anal Cancer, Cervical Cancer, Oral and oropharyngeal cancer ,liver cancer, skin cancer and also Kaposi's sarcoma are most prevalent among HIV patients. At the recent ASCO presentation, study led by doctors at Fred Hutchinson Cancer Research Center showed that pati...

New Strategies For HIV Vaccine

Source: La Jolla Institute for Immunology, California May 11, 2019 6 years ago

A new HIV vaccine delivery strategy appears to enhance the protective immune response in a preclinical model. Scientists at the La Jolla Institute for Immunology (LJI) have discovered that delivering an HIV vaccine in small doses over a series of days leads to a stronger immune response than when the same vaccine is given all at once. A similar escalating dose method could be the best way...

New antibody,UB-421, may suppress HIV for up to four months

Source: NIH/National Institute of Allergy and Infectious Diseases,US Apr 18, 2019 6 years ago

Regular infusions of an antibody that blocks the HIV binding site on human immune cells may have suppressed levels of HIV for up to four months in people undergoing a short-term pause in their antiretroviral therapy (ART) regimens, according to a report published online today in The New England Journal of Medicine. Results of the Phase 2, open-label study indicate the antibody, known as UB-42...

Antibiotic Cotrimoxazole found to reduce adverse effects in HIV patients.

Source: The London School of Medicine (Blizard Institute) Apr 05, 2019 6 years ago

A recent research found that long-term cotrimoxazole treatment reduces mortality and morbidity in children with HIV by altering their gut microbiome and immune activation. The finding supports current WHO guidelines, which recommend long-term cotrimoxazole treatment for all HIV-positive people living in areas where malaria and severe bacterial infections are common. Previous studies have shown...

Long-acting injectable treatment maintains HIV viral suppression.

Source: Conference on Retroviruses and Opportunistic Infections (CROI 2019) ,Seattle. Mar 10, 2019 6 years ago

A combination of two long-acting injectable anti-HIV drugs taken once monthly had a very low rate of treatment failure and a favourable safety profile, according to results from two phase III trials presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2019) in Seattle. Dual injections of cabotegravir, an experimental integrase inhibitor, and the no...

Cofilin, a T cell marker could help lead to improved treatment for HIV and also cancer patients

Source: George Mason University Feb 15, 2019 6 years ago

George Mason University's Yuntao Wu is the lead scientist on a research team that has identified a measurable indicator that could prove instrumental in the fight against HIV. The research focuses on cofilin, a key protein that regulates cells to mobilize and fight against infection. In an HIV-infected patient, cofilin dysfunction is a key factor in helper T cell defects, according to the r...

New Insights Into HIV For Possible Vaccine

Source: Simon Fraser University Feb 03, 2019 6 years ago

The immune system is the body's best defense in fighting diseases like HIV and cancer. Now, an international team of researchers is harnessing the immune system to reveal new clues that may help in efforts to produce an HIV vaccine. SFU professor Mark Brockman and co-authors from the University of KwaZulu-Natal in South Africa have identified a connection between infection cont...

‘Hidden HIV’ can now be accurately measured

Source: Howard Hughes Medical Institute Jan 31, 2019 6 years ago

Researchers can now quickly and accurately count a hidden, inactive form of the human immunodeficiency virus (HIV) that lurks in patients' cells. This version of HIV embeds into cells' genomes and can persist despite otherwise successful therapies, thwarting attempts to cure the infection. Using a new genetic technique developed by Howard Hughes Medical Institute Investigator Robert Sil...

Yale scientists examine how an immune system protein helps suppress HIV

Source: Yale University Jan 24, 2019 6 years ago

Much of the research on HIV has focused on preventing infection but little is understood about how the body keeps the virus in check post-infection. A new study by Yale investigators reveals the role of a protein that serves to block HIV gene expression once it has entered human cells. The research team, led by Manabu Taura, a postdoctoral fellow in the laboratory of immunobiologist ...

Study Of NEF Protein Released Due To HIV Infection Could Lead To New Therapeutic Developments

Source: Massachusetts General Hospital Jan 13, 2019 6 years ago

A study from a Massachusetts General Hospital (MGH) research team has identified the specific function of a protein found in HIV and related viruses that appears to slow down viral spread in the earliest stages of infection. But they also found that, after initially slowing down the spread of infection, that function may help the virus survive later on by evading the immune response. Their report ...

Targeting HIV Viral Reservoirs – The Next Frontier in the AIDS Battle.

Source: Pasteur Institute Jan 01, 2019 6 years ago

Current HIV treatments need to be taken for life by those infected as antiretroviral therapy is unable to eliminate viral reservoirs lurking in immune cells. Institut Pasteur scientists have identified the characteristics of CD4 T lymphocytes that are preferentially infected by the virus – it is their metabolic (or energy-producing) activity1 that enables the virus to multiply. Thanks to met...

Study shows that Testosterone may aid HIV male patients with better BMD (bone mineral density).

Source: Mary Ann Liebert, Inc Dec 13, 2018 6 years ago

A new study has shown that HIV-infected men had lower median bone mineral density (BMD) scores at the hip compared to HIV-uninfected men, and all men who received testosterone had significantly greater BMD scores at the lumbar spine. Further, in HIV-infected men with virologic suppression testosterone was significantly associated with a higher BMD score at the lumbar spine, as reported in AID...

TRIM5-alpha plays an important role in the HIV fight.

Source: University Of Montreal Dec 01, 2018 6 years ago

Of the 50 million people around the world infected with HIV, less than one per cent have immune systems strong enough to suppress the virus for extended periods of time. These special immune systems are known as "elite controllers." But how do they actually fight HIV? Canadian scientists think they've found an important clue. TRIM5 Alpha protein Working in collaboration with a team...

Study shows that manipulating CD8 T cell behavior is the key to HIV Suppression In the infected.

Source: Johns Hopkins University Of Medicine Nov 28, 2018 6 years ago

Researchers at Johns Hopkins have identified two patients with HIV whose immune cells behave differently than others with the virus and actually appear to help control viral load even years after infection. Moreover, both patients carry large amounts of virus in infected cells, but show no viral load in blood tests. While based on small numbers, the data suggest that long-term viral remission migh...

HIV latency in the various body tissues varies.

Source: Public Library Of Science, US Nov 16, 2018 6 years ago

Mechanisms that govern HIV transcription and latency differ in the gut and blood, according to a study published November 15 in the open-access journal PLOS Pathogens by Steven Yukl of San Francisco Veterans Affairs Medical Center and the University of California, San Francisco, and colleagues. According to the authors, the findings could inform new therapies aimed at curing HIV. HIV R...

Future Trends In PrEP, moving beyond Truvada.

Source: University of California Nov 01, 2018 6 years ago

Researchers are investigating other antiretrovirals, antibodies, injectables, implants, vaginal rings, vaginal films and other products Oral pre-exposure prophylaxis (PrEP) based on tenofovir disoproxil fumarate /emtricitabine (Truvada)has set a high bar for prevention effectiveness, but a range of alternative PrEP products are in development, Raphael Landovitz of the University of...

New single-tablet regimens show long-term effectiveness in HIV management according to studies.

Source: IDWeek2018 Oct 25, 2018 6 years ago

The newest once-daily, all-in-one HIV combination pills can maintain undetectable viral load for two years and counting, according to a set of studies presented at ID Week 2018 this month in San Francisco. Two phase 3 clinical trials showed that most people who took the bictegravir-based Biktarvy co-formulation or the doravirine-based Delstrigo pill for first-line t...

Interesting Reads

SARS-CoV-2 XEC Variant Shows Enhanced Immune Evasion through NTD Glycosylation

Nikhil Prasad
Oct 24, 2024 2 months ago

Many exposed to COVID-19 will develop Acute Ischemic Colitis!

Nikhil Prasad
Oct 21, 2024 2 months ago

Breaking News! Study Reveals Potential New Form of Brain Neurodegeneration Linked to COVID-19!

Nikhil Prasad
Oct 02, 2024 3 months ago

Word-Finding Challenges Linked to Post-COVID-19 Syndrome

Nikhil Prasad
Oct 02, 2024 3 months ago

Italian study discovers new subtype of T-cells as immune players in COVID-19

Nikhil Prasad
Sep 29, 2024 3 months ago

Texas scientist warns of new SARS-CoV-2 neuroinvasion pathway involving the trigeminal nerve

Nikhil Prasad
Sep 26, 2024 3 months ago

Researchers warn that SARS-CoV-2 can infect the Meibomian glands of the eyes

Nikhil Prasad
Jul 26, 2024 5 months ago

SARS-CoV-2 spike protein accelerates aging of blood vessels

Nikhil Prasad
Jul 23, 2024 5 months ago

Forget about the KP.3, LB.1, KP.2.3 variants. The new SARS-CoV-2 KP.3.1.1 is leading the current global COVID-19 surge

Nikhil Prasad
Jul 21, 2024 5 months ago

SARS-CoV-2 Causes ACE2 Downregulation and Unique Fibrosis That Contribute to Long COVID-19

Nikhil Prasad
Jun 28, 2024 6 months ago

COVID-19 and Stroke: New Insights on Inflammation and Recovery

Nikhil Prasad
Jun 22, 2024 6 months ago

Herbs And Phytochemicals: Oleuropein From Olive Leaf Can Help Against Colorectal Cancer

Nikhil Prasad
Jun 15, 2024 6 months ago

COVID-19 News: Researchers Warn That SARS-CoV-2 Infections Can Lead To Splenic Infarctions!

Nikhil Prasad
Dec 14, 2023 1 year ago

BREAKING COVID-19 News! SARS-CoV-2 Affects Red Blood Cell Morphology!

Nikhil Prasad
Oct 04, 2023 1 year ago

Study Shockingly Shows That Many Exposed To The SARS-CoV-2 Omicron Variant Exhibit Hematuria And Proteinuria! Early Signs Of Possible Kidney Damage?

COVID-19-News-Omicron-Hematuria-Proteinuria-Kidney-Damage
May 30, 2023 2 years ago

Phenolic Phytochemicals From The Roselle Plant Or Hibiscus Sabdariffa (Thai: Krachiap กระเจี๊ยบ) Can Treat And Prevent Obesity

Herbs And Phytochemicals - Roselle - Obesity
Mar 08, 2023 2 years ago

COVID-19 News: Will SARS-CoV-2 Infections Ultimately Lead To An Increased Incidence Of Head And Neck Cancers?

COVID-19 News - Head And Neck Cancers - By Nikhil P & Kittisak M
Feb 02, 2023 2 years ago

Study Validates Previous Findings That SARS-CoV-2 Reinfections Are Now Occurring At Shorter Intervals. Current CDC and ECDC Reinfection Definitions Are Obsolete!

Source: Medical News - SARS-CoV-2 Reinfections - Omicron
Sep 28, 2022 2 years ago

Quercetin Emerging As One Of The Must Take COVID-19 Supplements Especially When Considering The Omicron Variant And Long COVID-19 Issues

Source: COVID-19 Supplements - Quercetin
Jan 02, 2022 3 years ago

BREAKING! New International Study Warns That SARS-CoV-2 Infections Will Lead To Cancers Especially Colorectal Cancers Due to Disruption In Autophagy!

Source: SARS-CoV-2-Cancer
Nov 18, 2021 3 years ago

BREAKING! COVID-19 Genetics: Yale Scientist Identify Eight ‘Super’ Genetic Variants In White People That Increases COVID-19 Death Risk!

Source: COVID-19 Genetics
Nov 13, 2020 4 years ago

Japanese Study Shows That Ozone Water Rapidly Inactivates SARS-Cov-2 Coronavirus, Making It An Ideal COVID-19 Disinfectant And Sanitizer

Source: Ozone Water-COVID-19
Nov 05, 2020 4 years ago

BREAKING NEWS! COVID-19 Study Reveals That SARS-CoV-2 Uses CD4 Cells To Infect T-helper Lymphocytes. COVID-19 A Potent Version Of Airborne HIV?

Source: BREAKING NEWS
Sep 30, 2020 4 years ago

COVID-19 News: Emerging Studies Shows SARS-CoV-2 Attacks The Digestive Tract Especially The Intestines Directly, Reported Case Of Bowel Perforation

Source: COVID-19 News
Sep 21, 2020 4 years ago

BREAKING NEWS! Study Of COVID-19 Recovered Patients In China Reveals That Lymphocytes Are Drastically Altered To Become Dysfunctional With Immunity Implications

Source: COVID-19 Recovered Patients
Jul 02, 2020 5 years ago

Occulus Hirsutus and AQCH: India Discreetly Developing And Testing COVID-19 Drug Based On Phytochemicals Extracted From Occulus Hirsutus Plant

Source: Occulus Hirsutus and AQCH
Jun 27, 2020 5 years ago

High-Flow Nasal Cannula: For COVID-19 Second Wave Preparations, Forget About Ventilators, Doctors Are Now Turning To High-Flow Nasal Cannula

Source: High-Flow Nasal Cannula
Jun 25, 2020 5 years ago

BREAKING! Androgens: Study Shows Bald Men Mostly Likely To Suffer Severe COVID-19 Conditions Due To High Levels Of Androgens

Source: Androgens And COVID-19
Jun 23, 2020 5 years ago

BREAKING NEWS! COVID-19 Research Shows That SARS-CoV-2 Coronavirus Can Survive In Water For Up To 25 Days And Could Also Be Water-Borne

Source: COVID-19 Research
Jun 23, 2020 5 years ago

BREAKING! Hepatitis B: UAE COVID-19 Case Study Indicates That COVID-19 Could Induce Hepatitis B Virus Reactivation

Source: Hepatitis B and COVID-19
Jun 21, 2020 5 years ago

BREAKING! COVID-19 Research: Sodium Channels Could Be Affected As Coronavirus Spike Protein Has Similar Sequence To Human Epithelial Sodium Channel

Source: COVID-19 Research
Jun 21, 2020 5 years ago

BREAKING! Cannabis And COVID-19: Caflanone, A Flavonoid Extracted From A Distinct Cannabis Strain Could be A Therapeutic Drug Against the COVID-19

Source: Cannabis And COVID-19
Jun 20, 2020 5 years ago

Gargling: New Studies Show That Throat Gargling May Be Beneficial After All During COVID-19 Despite Being Labeled In the Past As Misinformation

Source: Gargling and COVID-19
Jun 19, 2020 5 years ago

BREAKING! COVID-19 Research: New Study Reveals That SARS-CoV-2 Coronavirus Also Affects Thyroid Functions In Majority Of COVID-19 Patients

Source: COVID-19 Research
Jun 17, 2020 5 years ago

Exploring Inhaled Nitric Oxide (iNo) As As An Adjuvant COVID-19 Treatment For Pulmonary Issues

Source: Nitric Oxide and COVID-19
Jun 15, 2020 5 years ago

Understanding The Differences Between COVID-19 Asymptomatic and Presymptomatic Conditions

Source: COVID-19 Asymptomatic and Presymptomatic
Jun 14, 2020 5 years ago

Scripp Institute Has Detected The Mutation That Most Scientist Dread: The D614G Mutation Which Could Make The SARS-CoV-2 More Infectious

Source: SARS-CoV-2 Mutations
Jun 13, 2020 5 years ago

BREAKING! Medical Experts Warn That COVID-19 Could Trigger Diabetes In Otherwise Healthy Individuals Who Never Had The Condition Before.

Source: Diabetes and COVID-19
Jun 13, 2020 5 years ago

Acute Pancreatitis: Warning That Acute Pancreatitis Is Now Manifesting In COVID-19 Patients, A Condition Never Seen In Early Stages Of The Pandemic

Source: Acute Pancreatitis
Jun 11, 2020 5 years ago

Immune Health: Cistanche And Pu-erh Tea Supplements Could Help Improve Immune Factors And Reduce Pro-inflammatory Cytokines Such As Interleukin-6

Source: Immune Health
Jun 09, 2020 5 years ago

Study Finds That COVID-19 Also Causes Myocardial Injury (Heart Damage)

Source: Myocardial Injury
Jun 09, 2020 5 years ago

European COVID-19 Research Indicates That Individuals With Blood Group Type A Might Be More Vulnerable To Respiratory Failure

Source: COVID-19 Research
Jun 08, 2020 5 years ago

Supplements: Singaporean Researchers Say That Vitamin D, Magnesium And Vitamin B12 Combo May Reduce Severity In Older COVID-19 Patients

Source: Supplements And COVID-19
Jun 06, 2020 5 years ago

MUST READ! Strokes: Study Shows COVID-19 Increases Risk Of Strokes In Healthy Young Individuals. Global Increase In Stroke Deaths Last Few Months

Source: Strokes And COVID-19
Jun 05, 2020 5 years ago

BREAKING ALERT! COVID-19: Italian Researchers Discover Brain Lesions On COVID-19 Patients

Source: COVID-19
May 23, 2020 5 years ago

FROM NURSING NEWS

LATEST ON COVID-19 NEWS

World COVID-19 News

COVID-19 Diagnostics

COVID-19 Drugs

COVID-19 Supplements

COVID-19 Herbs

COVID-19 Disinfectants

COVID-19 Mutations

COVID-19 Research

COVID News

Long COVID

COVID-19 Vaccines

COVID-19 Clinical Care

Medical Press Releases

Medical Innovations & Startups

AI in Medicine

Thailand Biotech News

Medical Spheres Bulletins

Medical White Papers

Medical Packages

Medical Tips

Medical Support Groups

MOST READ

Interesting Reads

FROM NURSING NEWS

LATEST ON COVID-19 NEWS